Elizabeth Ingram
Chief Executive Officer at Cipla Therapeutics, Inc.
Profile
Elizabeth G.
Ingram is currently the President & Chief Executive Officer at Cipla Therapeutics, Inc. She previously served as an Independent Director at Avenue Therapeutics, Inc. from 2019 to 2022.
Prior to that, she was the Vice President-Market Access Strategy at Bristol Myers Squibb Co. from 2012 to 2014.
Elizabeth also held the position of Chief Marketing Officer at MannKind Corp.
in 2018 and was the Senior Vice President-Managed Market at DexCom, Inc. in 2017.
She completed her undergraduate degree at East Carolina University and her graduate degree at the University of South Carolina.
Elizabeth Ingram active positions
| Companies | Position | Start |
|---|---|---|
| Cipla Therapeutics, Inc. | Chief Executive Officer | - |
Former positions of Elizabeth Ingram
| Companies | Position | End |
|---|---|---|
| AVENUE THERAPEUTICS, INC. | Director/Board Member | 30/10/2022 |
| MANNKIND CORPORATION | Sales & Marketing | 31/05/2019 |
| DEXCOM, INC. | Corporate Officer/Principal | 30/11/2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/12/2013 |
Training of Elizabeth Ingram
| East Carolina University | Undergraduate Degree |
| University of South Carolina | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| DEXCOM, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AVENUE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
| Cipla Therapeutics, Inc. |
- Stock Market
- Insiders
- Elizabeth Ingram
